Clinical utility of far-infrared therapy for improvement of vascular access blood flow and pain control in hemodialysis patients
- Authors
- Choi, Soo Jeong; Cho, Eun Hee; Jo, Hye Min; Min, Changwook; Ji, Young Sok; Park, Moo Yong; Kim, Jin Kuk; Hwang, Seung Duk
- Issue Date
- Mar-2016
- Publisher
- 대한신장학회
- Keywords
- Arteriovenous fistula; Far-infrared therapy; Hemodialysis; Pain
- Citation
- Kidney Research and Clinical Practice, v.35, no.1, pp 35 - 41
- Pages
- 7
- Journal Title
- Kidney Research and Clinical Practice
- Volume
- 35
- Number
- 1
- Start Page
- 35
- End Page
- 41
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/9298
- DOI
- 10.1016/j.krcp.2015.12.001
- ISSN
- 2211-9132
2211-9140
- Abstract
- Background: Maintenance of a well-functioning vascular access and minimal needling pain are important goals for achieving adequate dialysis and improving the quality of life in hemodialysis (HD) patients. Far-infrared (FIR) therapy may improve endothelial function and increase access blood flow (Qa) and patency in HD patients. The aim of this study was to evaluate effects of FIR therapy on Qa and patency, and needling pain in HD patients. Methods: This prospective clinical trial enrolled 25 outpatients who maintained HD with arteriovenous fistula. The other 25 patients were matched as control with age, sex, and diabetes. FIR therapy was administered for 40 minutes during HD 3 times/wk and continued for 12 months. The Qa was measured by the ultrasound dilution method, whereas pain was measured by a numeric rating scale at baseline, then once per month. Results: One patient was transferred to another facility, and 7 patients stopped FIR therapy because of an increased body temperature and discomfort. FIR therapy improved the needling pain score from 4 to 2 after 1 year. FIR therapy increased the Qa by 3 months and maintained this change until 1 year, whereas control patients showed the decrease in Qa. The 1-year unassisted patency with FIR therapy was not significantly different from control. Conclusion: FIR therapy improved needling pain. Although FIR therapy improved Qa, the unassisted patency was not different compared with the control. A larger and multicenter study is needed to evaluate the effect of FIR therapy. Copyright (C) 2016. The Korean Society of Nephrology. Published by Elsevier.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Internal Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/9298)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.